Evaluation of Single Session Stereotactic Body Radiotherapy
Primary Purpose
Spinal Neoplasms
Status
Active
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Stereotactic Body Radiotherapy
Sponsored by
About this trial
This is an interventional treatment trial for Spinal Neoplasms focused on measuring Spinal Neoplasms, Paraspinal Metastases, Stereotactic Body Radiotherapy, CT-on-Rails, Spinal Cord, SBRT
Eligibility Criteria
Inclusion Criteria:
- Radiographically documented spine or paraspinal metastasis demonstrated on spine MRI within 4 weeks of registration
- Maximum of 2 metastatic sites in the spine to be irradiated in single session
- Informed consent for irradiation of spinal or para-spinal tumor (s)
- Diagnosis of cancer including but not limited to lung (non-small cell and small cell), breast, prostate, renal cell, melanoma, gastrointestinal, and germ cell tumors, unknown primary tumors
- Karnofsky performance status of at least 40 (ie not requiring active hospitalization)
Exclusion Criteria:
- Worsening neurological status due to radiographic evidence of spinal cord compression requiring immediate surgical decompression or emergent conventional external radiation therapy.
- Delay in initiation of radiation treatment would be potentially detrimental to neurological outcome
- Prior irradiation to current site of interest in the spine
- Spinal metastasis in the cervical spine are not eligible for treatment
- Unstable spine requiring surgical stabilization.
- Sites outside the spine (eg. lung, liver) are not eligible for treatment
- Patients currently receiving, or who have received chemotherapy within 30 days are not eligible
- Inability to tolerate lying flat on treatment couch for greater than 30 minutes.
- Patient with multiple myeloma
- Patients unable to undergo MRI of the spine
- Patients with pacemakers
Sites / Locations
- University of Texas MD Anderson Cancer Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Single Session Stereotactic Body Radiotherapy (SBRT)
Arm Description
On day 1 of radiation treatment, a CT scan using CT-on-Rails in the same treatment room, immediately before the radiation treatment will be performed.
Outcomes
Primary Outcome Measures
Complete Pain Relief Using Stereotactic Body Radiotherapy (SBRT) to Treat Spine and para-Spinal Tumors in a Single Session
The validated Brief Pain Inventory (BPI), MD Anderson Symptom Inventory (MDASI), and SF-12v2 Health Survey used to assess changes in these indicators compared to pre-treatment baseline. Response determined by follow-up questionaires. Time to maximal pain relief will be the time from the first day of irradiation until the lowest pain score for average pain after radiotherapy. The "worst pain score" from BPI used as the marker for treatment success or failure.
Secondary Outcome Measures
Full Information
NCT ID
NCT00492817
First Posted
June 26, 2007
Last Updated
September 1, 2023
Sponsor
M.D. Anderson Cancer Center
1. Study Identification
Unique Protocol Identification Number
NCT00492817
Brief Title
Evaluation of Single Session Stereotactic Body Radiotherapy
Official Title
Phase I/II Evaluation of Single Session Stereotactic Body Radiotherapy for Spinal or Paraspinal Metastases
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
October 2005 (Actual)
Primary Completion Date
October 31, 2024 (Anticipated)
Study Completion Date
October 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this clinical research study is to find out if stereotactic body radiotherapy to the spine using computerized tomography (CT)-on-Rails is safe and effective in the treatment of metastatic spine tumors.
Objectives:
Establish the safety and efficacy of using stereotactic body radiotherapy (SBRT) to treat spine and para-spinal tumors in a single session.
Document frequency and severity of pain, symptoms and symptom interference, as well as quality of life before and after treatment.
Document changes in neurological function at defined intervals compared to pre-treatment neurological function.
Detailed Description
CT-on-Rails is a system that places the radiation treatment machine in the same room as the CT scanner so that the CT scanner can help deliver radiation more precisely.
You will have a MRI of the spine within 1 month before registration on this study. You will also fill out a health survey, a symptom inventory, and a Brief Pain Inventory within 1 week before registration. Each of these surveys should take about 5 minutes to complete. You will have a CT-simulation. The simulation is like a CT scan where a special body frame is used to keep you from moving during scanning and later radiation treatment. However, no radiation is delivered during the simulation. You will be asked questions about your medical history and have a complete neurological exam during your first consultation, before registration. The neurological exam involves testing upper and lower motor strength, sensation to light touch, reflexes, a mental exam, and an evaluation of the way you walk.
Radiation treatment will last between 2 and 2 1/2 hours and will be given on 1 day about 1 to 1 1/2 weeks after you had the simulation. You will have a device (similar to plastic wrap) placed around you that will hold you still during the treatment. You will be checked for level of pain and/or discomfort before starting each session of radiation, and you may take pain medications before starting each session. All participants will be treated with radiation therapy that is guided by the CT-on-Rails procedure. On the day of radiation, you will also receive a CT scan using CT-on-Rails in the same treatment room, immediately before the radiation treatment.
During treatment, a physician will be monitoring you for any side effects. If you experience severe side effects, radiation treatment will be stopped, and you will be taken off study. After treatment on this study ends, you will have telephone, mail, or facsimile (Fax) follow-ups scheduled at 1, 2, 3, 4, and 8 weeks after radiation. You will be asked questions about any side effects or pain you are experiencing and any other therapies you may have started.
You will have follow-up visits scheduled at 3, 6, 9, 12, 18, and 24 months and then every 6 months for the rest of your life. At all follow-up visits, you will be asked questions about your medical history, have a neurological exam, and your neurologic function will be evaluated. Any pain medication you are taking will be noted. You will be asked to have a MRI of the spine at 3, 6, 9, 12,18, and 24 months, then once a year for the rest of your life. You will also be asked to complete 3 questionnaires to evaluate your symptoms, pain, and quality of life at each follow-up visit. Each questionnaire should take around 5 minutes to complete.
This is an investigational study. The equipment used in this study are FDA-approved medical devices and are commercially available. However, the way the devices are being used in this study is experimental. Up to 60 patients will take part in this study. All will be enrolled at M. D. Anderson.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Neoplasms
Keywords
Spinal Neoplasms, Paraspinal Metastases, Stereotactic Body Radiotherapy, CT-on-Rails, Spinal Cord, SBRT
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
71 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single Session Stereotactic Body Radiotherapy (SBRT)
Arm Type
Experimental
Arm Description
On day 1 of radiation treatment, a CT scan using CT-on-Rails in the same treatment room, immediately before the radiation treatment will be performed.
Intervention Type
Procedure
Intervention Name(s)
Stereotactic Body Radiotherapy
Other Intervention Name(s)
SBRT
Intervention Description
On day 1 of radiation treatment, a CT scan using CT-on-Rails in the same treatment room, immediately before the radiation treatment will be performed.
Primary Outcome Measure Information:
Title
Complete Pain Relief Using Stereotactic Body Radiotherapy (SBRT) to Treat Spine and para-Spinal Tumors in a Single Session
Description
The validated Brief Pain Inventory (BPI), MD Anderson Symptom Inventory (MDASI), and SF-12v2 Health Survey used to assess changes in these indicators compared to pre-treatment baseline. Response determined by follow-up questionaires. Time to maximal pain relief will be the time from the first day of irradiation until the lowest pain score for average pain after radiotherapy. The "worst pain score" from BPI used as the marker for treatment success or failure.
Time Frame
3 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Radiographically documented spine or paraspinal metastasis demonstrated on spine MRI within 4 weeks of registration
Maximum of 2 metastatic sites in the spine to be irradiated in single session
Informed consent for irradiation of spinal or para-spinal tumor (s)
Diagnosis of cancer including but not limited to lung (non-small cell and small cell), breast, prostate, renal cell, melanoma, gastrointestinal, and germ cell tumors, unknown primary tumors
Karnofsky performance status of at least 40 (ie not requiring active hospitalization)
Exclusion Criteria:
Worsening neurological status due to radiographic evidence of spinal cord compression requiring immediate surgical decompression or emergent conventional external radiation therapy.
Delay in initiation of radiation treatment would be potentially detrimental to neurological outcome
Prior irradiation to current site of interest in the spine
Spinal metastasis in the cervical spine are not eligible for treatment
Unstable spine requiring surgical stabilization.
Sites outside the spine (eg. lung, liver) are not eligible for treatment
Patients currently receiving, or who have received chemotherapy within 30 days are not eligible
Inability to tolerate lying flat on treatment couch for greater than 30 minutes.
Patient with multiple myeloma
Patients unable to undergo MRI of the spine
Patients with pacemakers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amol J. Ghia, MD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas MD Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
12. IPD Sharing Statement
Links:
URL
http://www.mdanderson.org
Description
M D Anderson Cancer Center
Learn more about this trial
Evaluation of Single Session Stereotactic Body Radiotherapy
We'll reach out to this number within 24 hrs